The role of the chemotactic cytokines in in tick-borne encephalitis – the observational clinical study

preprint OA: closed
Full text JSON View at publisher
AI-generated deep summary by claude@2026-06, 2026-06-24 · read from full text

This observational clinical study analyzed serum and cerebrospinal fluid (CSF) from 103 tick-borne encephalitis (TBE) patients and compared them with serum (n=19) and CSF (n=12) controls to determine which chemotactic cytokines relate to CSF pleocytosis and clinical severity. Using a micro-bead assay/ELISA for multiple chemokines, cytometric counting of CSF lymphocyte subpopulations, and genotyping of polymorphisms in chemokine-receptor genes, the study found that—except for CXCL2, CCL5, and XCL1—most CSF chemokines were increased and consistent with intrathecal synthesis; CXCL1, IL-8, CXCL10, CCL2, CCL3, CCL19, and CCL20 formed gradients toward CSF in 90–100% of patients, and different chemokines associated with predominantly neutrophil versus lymphocyte infiltration. CCL11, CCL19, CXCL10, and CXCL13 were associated with milder presentation, whereas CXCL1 and CCL20 correlated with more severe disease, and genetic variants in several receptor/chemokine genes were linked to chemokine levels. This paper is a preprint and not peer reviewed, though it concludes that distinct chemotactic axes may contribute to pleocytosis and that protective vs immunopathogenic effects can be separated, informing leukocyte influx complexity. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 17,291 characters · extracted from preprint-html · click to expand
The role of the chemotactic cytokines in in tick-borne encephalitis – the observational clinical study | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article The role of the chemotactic cytokines in in tick-borne encephalitis – the observational clinical study Sambor Grygorczuk, Piotr Czupryna, Diana Martonik, Anna Parfieniuk-Kowerda, and 7 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4643861/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background In tick-borne encephalitis (TBE), central nervous system is infiltrated by a mixed leukocyte population detectable as cerebrospinal fluid (CSF) pleocytosis, contributing both to an infection control and immune-mediated pathology. The chemotactic pathways controlling this leukocyte influx are not well defined. Results We studied serum and CSF samples from 103 TBE patients, using normal serum (n=19) and CSF (n=12) as controls. We measured concentrations of the chemotactic cytokines IL-16, CXCL1, CXCL2, CXCL5, CXCL6, IL-8, CXCL9, CXCL10, CXCL11, CXCL13, CCL2, CCL3, CCL4, CCL5, CCL7, CCL8, CCL11, CCL13, CCL17, CCL19, CCL20, CCL21, CX3CL1 and XCL1 with a micro-bead assay and of CXCL12 with ELISA. The CSF lymphocyte subpopulations were counted cytometrically with a fluorescent-labeled monoclonal antibody kit. DNA was isolated from patients’ blood samples and 10 polymorphisms in CCR2 , CCL5 , CCR5 , CXCR3 , CXCL10 , CXCL11 and CX3CR1 genes studied with real-time PCR. We analyzed results with non-parametric tests and created multivariate linear regression models of leukocyte population counts in CSF and of the clinical severity dependent on chemokine CSF levels. Except of CXCL2, CCL5 and XCL1, all the CSF chemokine concentrations were increased and the concentration index values favored their intrathecal synthesis. CXCL1, IL-8, CXCL10, CCL2, CCL3, CCL19 and CCL20 created chemotactic gradients towards CSF in 90-100% and CCL4, CCL7, CCL8 in about half of patients. The neutrophils associated predominantly with CXCL1 and IL-8 and the lymphocytes with IL-16, CCL19, CCL20, CCL4, CXCL12 and CXCL13, with consistent negative associations with CX 3 CL1 and CCL2. CCL11, CCL19, CXCL10 and CXCL13 associated with milder and CXCL1 and CCL20 with a more severe presentation. There were associations between the genotypes of CCR2, CCL5, CXCR3 and CX3CR1 and concentrations of the relevant chemokines. Conclusions CXCL1/CXCR2, IL-8/CXCR1, CCL19/CCR7, CCL20/CCR6, CCL4/CCR5, CXCL12/CXCR4, CXCL13/CXCR5 and possibly other signaling axes contribute to pleocytosis in TBE. IL-16 associates with pleocytosis in an unclear mechanism and CX 3 CL1 may be an antagonist of the leukocyte influx. The protective/immunopathogenic effects of chemokines are can be distinguished from their chemotactic effects, suggesting a complex relation between the inflammatory infiltrate and the clinical outcome. The genetic background influences chemokine expression in TBE. tick-borne encephalitis cerebrospinal fluid intrathecal immunity pleocytosis chemotaxis chemokines Full Text Additional Declarations No competing interests reported. Supplementary Files AdditionalFile1.tif AdditionalFile2.docx AdditionalFile3.docx AdditionalFile4.docx Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4643861","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":323312562,"identity":"9881214b-fe6e-4b98-9f0d-73506dc1e420","order_by":0,"name":"Sambor Grygorczuk","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA90lEQVRIiWNgGAWjYFADHjB5gIGBvQHEsCBFC88BEEOCFC0SCfi1yEefMX7xcY+dvcGZA8wffubckTOf+fjYA8YduLUYnssxs5zxLJnZ4GwDm2TvtmfGMrfT0g0Yz+DR0sNjZsxz4ACbwXkGNgbebYcTZ0jnmEkwthHWwgPUwvzxL0iL5Bn8WuR5eIwfA7VIAB3GIA22RYIHvxYDHrYyxhkHkg0kzxxsk5YF+kWCB+iXRDx+ke9h3vzhwwE7e74zyYc/vt12R06C/fCxBx932OC25QCHGdRAxgaYIBtDYgN25WBbGtgff0AXZEPSPgpGwSgYBaOAAQBlvlQhDFpRJQAAAABJRU5ErkJggg==","orcid":"","institution":"Medical University in Białystok","correspondingAuthor":true,"prefix":"","firstName":"Sambor","middleName":"","lastName":"Grygorczuk","suffix":""},{"id":323312563,"identity":"8558193a-e332-400a-b827-c3fa179b58da","order_by":1,"name":"Piotr Czupryna","email":"","orcid":"","institution":"Medical University in Białystok","correspondingAuthor":false,"prefix":"","firstName":"Piotr","middleName":"","lastName":"Czupryna","suffix":""},{"id":323312564,"identity":"ee72e420-63db-4437-92ba-45e9b26e3c9a","order_by":2,"name":"Diana Martonik","email":"","orcid":"","institution":"Medical University in Białystok","correspondingAuthor":false,"prefix":"","firstName":"Diana","middleName":"","lastName":"Martonik","suffix":""},{"id":323312565,"identity":"d01123f9-6d4a-433a-bea7-c09a911fa077","order_by":3,"name":"Anna Parfieniuk-Kowerda","email":"","orcid":"","institution":"Medical University in Białystok","correspondingAuthor":false,"prefix":"","firstName":"Anna","middleName":"","lastName":"Parfieniuk-Kowerda","suffix":""},{"id":323312566,"identity":"fccf21c0-d2f1-4d63-ab4f-665b7a2a8eec","order_by":4,"name":"Justyna Adamczuk","email":"","orcid":"","institution":"University Hospital in Białystok","correspondingAuthor":false,"prefix":"","firstName":"Justyna","middleName":"","lastName":"Adamczuk","suffix":""},{"id":323312567,"identity":"fde1ef05-78ba-4541-a568-9c308883ecf3","order_by":5,"name":"Justyna Dunaj-Małyszko","email":"","orcid":"","institution":"Medical University in Białystok","correspondingAuthor":false,"prefix":"","firstName":"Justyna","middleName":"","lastName":"Dunaj-Małyszko","suffix":""},{"id":323312568,"identity":"0fc54ccc-014d-4c5a-97e3-f79d4035c26e","order_by":6,"name":"Maciej Giecko","email":"","orcid":"","institution":"Medical University in Białystok","correspondingAuthor":false,"prefix":"","firstName":"Maciej","middleName":"","lastName":"Giecko","suffix":""},{"id":323312570,"identity":"7293ac54-f285-4c2e-a3cc-370d591da7f3","order_by":7,"name":"Joanna Osada","email":"","orcid":"","institution":"Medical University in Białystok","correspondingAuthor":false,"prefix":"","firstName":"Joanna","middleName":"","lastName":"Osada","suffix":""},{"id":323312571,"identity":"81b6f7bc-5bed-4d40-ae0e-6d56035096a8","order_by":8,"name":"Miłosz Parczewski","email":"","orcid":"","institution":"Pomeranian Medical University","correspondingAuthor":false,"prefix":"","firstName":"Miłosz","middleName":"","lastName":"Parczewski","suffix":""},{"id":323312575,"identity":"2aebbb0f-db3a-4dba-91e0-59a9770284e0","order_by":9,"name":"Robert Flisiak","email":"","orcid":"","institution":"Medical University in Białystok","correspondingAuthor":false,"prefix":"","firstName":"Robert","middleName":"","lastName":"Flisiak","suffix":""},{"id":323312576,"identity":"173dcf0f-2ff4-40b0-9d31-b261de63c28c","order_by":10,"name":"Anna Moniuszko-Malinowska","email":"","orcid":"","institution":"Medical University in Białystok","correspondingAuthor":false,"prefix":"","firstName":"Anna","middleName":"","lastName":"Moniuszko-Malinowska","suffix":""}],"badges":[],"createdAt":"2024-06-26 15:51:19","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4643861/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4643861/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":60653543,"identity":"49b6ee3e-bb1e-4731-b673-98c3f097047e","added_by":"auto","created_at":"2024-07-19 07:01:52","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":753641,"visible":true,"origin":"","legend":"","description":"","filename":"Grygorczuketal..pdf","url":"https://assets-eu.researchsquare.com/files/rs-4643861/v1_covered_f726b98c-2a07-4d0b-9efb-59863ed1b20c.pdf"},{"id":60652265,"identity":"7e2ef895-fff7-4b90-8184-94983cb5ce10","added_by":"auto","created_at":"2024-07-19 06:45:48","extension":"tif","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":1901136,"visible":true,"origin":"","legend":"","description":"","filename":"AdditionalFile1.tif","url":"https://assets-eu.researchsquare.com/files/rs-4643861/v1/448990b735033e60944e1c3f.tif"},{"id":60652263,"identity":"452f47d3-0415-4962-aa7c-3e0e7ba05c55","added_by":"auto","created_at":"2024-07-19 06:45:48","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":22859,"visible":true,"origin":"","legend":"","description":"","filename":"AdditionalFile2.docx","url":"https://assets-eu.researchsquare.com/files/rs-4643861/v1/95f45d3a93301460ce7a64f9.docx"},{"id":60652264,"identity":"49d001fe-fd4c-4c6f-b1db-c4caef98275b","added_by":"auto","created_at":"2024-07-19 06:45:48","extension":"docx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":23357,"visible":true,"origin":"","legend":"","description":"","filename":"AdditionalFile3.docx","url":"https://assets-eu.researchsquare.com/files/rs-4643861/v1/2fccb3c1c4607127b29a55ef.docx"},{"id":60652267,"identity":"78c2082e-664c-4b8e-98fd-99c54571cb1f","added_by":"auto","created_at":"2024-07-19 06:45:51","extension":"docx","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":24308,"visible":true,"origin":"","legend":"","description":"","filename":"AdditionalFile4.docx","url":"https://assets-eu.researchsquare.com/files/rs-4643861/v1/56bb7244c63bb99fddc23fe8.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"The role of the chemotactic cytokines in in tick-borne encephalitis – the observational clinical study","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"tick-borne encephalitis, cerebrospinal fluid, intrathecal immunity, pleocytosis, chemotaxis, chemokines","lastPublishedDoi":"10.21203/rs.3.rs-4643861/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4643861/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eBackground\u003c/p\u003e\n\u003cp\u003eIn tick-borne encephalitis (TBE), central nervous system is infiltrated by a mixed leukocyte population detectable as cerebrospinal fluid (CSF) pleocytosis, contributing both to an infection control and immune-mediated pathology. The chemotactic pathways controlling this leukocyte influx are not well defined.\u003c/p\u003e\n\u003cp\u003eResults\u003c/p\u003e\n\u003cp\u003eWe studied serum and CSF samples from 103 TBE patients, using normal serum (n=19) and CSF (n=12) as controls. We measured concentrations of the chemotactic cytokines IL-16, CXCL1, CXCL2, CXCL5, CXCL6, IL-8, CXCL9, CXCL10, CXCL11, CXCL13, CCL2, CCL3, CCL4, CCL5, CCL7, CCL8, CCL11, CCL13, CCL17, CCL19, CCL20, CCL21, CX3CL1 and XCL1 with a micro-bead assay and of CXCL12 with ELISA. The CSF lymphocyte subpopulations were counted cytometrically with a fluorescent-labeled monoclonal antibody kit. DNA was isolated from patients’ blood samples and 10 polymorphisms in \u003cem\u003eCCR2\u003c/em\u003e, \u003cem\u003eCCL5\u003c/em\u003e, \u003cem\u003eCCR5\u003c/em\u003e, \u003cem\u003eCXCR3\u003c/em\u003e, \u003cem\u003eCXCL10\u003c/em\u003e, \u003cem\u003eCXCL11\u003c/em\u003e and \u003cem\u003eCX3CR1\u003c/em\u003e genes studied with real-time PCR. We analyzed results with non-parametric tests and created multivariate linear regression models of leukocyte population counts in CSF and of the clinical severity dependent on chemokine CSF levels.\u003c/p\u003e\n\u003cp\u003eExcept of CXCL2, CCL5 and XCL1, all the CSF chemokine concentrations were increased and the concentration index values favored their intrathecal synthesis. CXCL1, IL-8, CXCL10, CCL2, CCL3, CCL19 and CCL20 created chemotactic gradients towards CSF in 90-100% and CCL4, CCL7, CCL8 in about half of patients. The neutrophils associated predominantly with CXCL1 and IL-8 and the lymphocytes with IL-16, CCL19, CCL20, CCL4, CXCL12 and CXCL13, with consistent negative associations with CX\u003csub\u003e3\u003c/sub\u003eCL1 and CCL2. CCL11, CCL19, CXCL10 and CXCL13 associated with milder and CXCL1 and CCL20 with a more severe presentation. There were associations between the genotypes of \u003cem\u003eCCR2, CCL5, CXCR3\u003c/em\u003e and \u003cem\u003eCX3CR1\u003c/em\u003e and concentrations of the relevant chemokines.\u003c/p\u003e\n\u003cp\u003eConclusions\u003c/p\u003e\n\u003cp\u003eCXCL1/CXCR2, IL-8/CXCR1, CCL19/CCR7, CCL20/CCR6, CCL4/CCR5, CXCL12/CXCR4, CXCL13/CXCR5 and possibly other signaling axes contribute to pleocytosis in TBE. IL-16 associates with pleocytosis in an unclear mechanism and CX\u003csub\u003e3\u003c/sub\u003eCL1 may be an antagonist of the leukocyte influx. The protective/immunopathogenic effects of chemokines are can be distinguished from their chemotactic effects, suggesting a complex relation between the inflammatory infiltrate and the clinical outcome. The genetic background influences chemokine expression in TBE.\u003c/p\u003e","manuscriptTitle":"The role of the chemotactic cytokines in in tick-borne encephalitis – the observational clinical study","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-07-19 06:45:44","doi":"10.21203/rs.3.rs-4643861/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"be543648-1c86-49c9-8e3d-9d1c6ca9c81f","owner":[],"postedDate":"July 19th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2024-07-19T06:45:46+00:00","versionOfRecord":[],"versionCreatedAt":"2024-07-19 06:45:44","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-4643861","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4643861","identity":"rs-4643861","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00